Immediate Impact
1 from Science/Nature 72 standout
Citing Papers
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)
2022 Standout
Works of Laura Catena being referenced
Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?
2005
Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours
2002
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Laura Catena | 744 | 611 | 445 | 47 | 985 | |
| Guillermo Crespo | 698 | 520 | 359 | 31 | 992 | |
| Lewis A. Johnson | 486 | 632 | 404 | 29 | 1.1k | |
| Mohid S. Khan | 798 | 771 | 508 | 46 | 963 | |
| Ruža Arsenić | 469 | 437 | 264 | 53 | 1.1k | |
| Leonardo Ferrari | 579 | 505 | 390 | 30 | 823 | |
| Mark Sawicki | 500 | 493 | 265 | 39 | 1.1k | |
| Volker Fendrich | 657 | 561 | 359 | 52 | 933 | |
| Natalie Prinzi | 654 | 367 | 187 | 70 | 1.1k | |
| Francesco Paolo Pilato | 305 | 530 | 253 | 41 | 980 | |
| Anna Sowa‐Staszczak | 536 | 659 | 429 | 68 | 932 |
All Works
Loading papers...